A B S T R A C T We photolabeled and characterized insulin receptors in isolated adipocytes from normal human subjects and then studied the cellular fate of the labeled insulin-receptor complexes at physiologic temperatures. The biologically active photosensitive insulin derivative, B2(2-nitro-4-azidophenylacetyl)des-PheBl_ insulin (NAPA-DP-insulin) was used to photoaffinity label the insulin receptors, and the specifically labeled cellular proteins were identified by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and autoradiography.
disulfide bonds with dithiothreitol, all three unreduced forms of the insulin receptor were converted into a major labeled Mr-125,000 band and a less intensely labeled M,-90,000 band. The labeling of the Mr-125,000 receptor subunit was saturable and native porcine insulin effectively inhibited (half-maximal inhibition at 12 ng/ml) the photolabeling of this binding subunit by NAPA-DP insulin.
When intact adipocytes photolabeled at 16°C (a temperature that inhibits endocytosis) were immediately trypsinized, all of the labeled receptor bands were converted into small molecular weight tryptic fragments, indicating that at 16°C all of the labeled insulinreceptor complexes remained on the cell surface. However, when the photolabeled cells were further incubated at 370C and then trypsinized, a proportion of the labeled receptors became trypsin insensitive, indicating that this fraction has been translocated to the cell interior and thus was inaccessible to the trypsin in the incubation medium. The intracellular translocation of the labeled receptors was observed within 2 min, became half-maximal by 10 min, and maximal by '-30 min of incubation at 370C. Cellular processing of the internalized insulin-receptor complexes also occurred, since incubation at 37°C (but not 16°C) resulted in the generation of a M,-115,000 component from the labeled receptors. Inclusion of chloroquine, a drug with lysosomotropic properties, in the incubation media caused a time-dependent increase (maximal increase of 50% above control by 2 h at 370C) in the intracellular pool of labeled receptors. In contrast to these findings in human adipocytes, no appreciable internalization of insulin-receptor complexes and no chloroquine effect INTRODUCTION One of insulin's well-recognized biologic actions is the ability to regulate inversely the number of its cell surface receptors. This process, termed "down regulation," was first reported by Gavin et al. (1) , using IM-9 lymphocytes, and has subsequently been demonstrated extensively in several other cell types (2) (3) (4) (5) . Furthermore, many pathophysiologic conditions such as obesity (6) (7) (8) , impaired glucose tolerance (9, 10) , and noninsulindependent diabetes mellitus (10) (11) (12) (13) are characterized by varying degrees of hyperinsulinemia, decreased numbers of cell surface insulin receptors, and insulin resistance. Amelioration of hyperinsulinemia has also been shown to result in return of the cell surface receptor concentration to normal (14) , thus suggesting that it is the hyperinsulinemia that leads to the receptor loss. In vitro evidence for this has been presented whereby incubation of isolated rat adipocytes with insulin led to a dose-dependent loss of cell-surface insulin receptors and a concomitant development of decreased sensitivity to insulin action at the glucose transport level (15) . Thus, the accumulating evidence indicates that insulin-induced receptor loss or down regulation may serve an important regulatory function for overall insulin action. However, the specific mechanisms by which the process takes place and the metabolic fate of the insulin receptor remain poorly understood. In rat adipocytes (16, 17) and hepatocytes (18, 19) , recent studies indicate that insulin receptors are internalized, but information regarding the cellular fate of insulin receptors in human tissues is lacking.
Although the isolated human adipocyte system has been used extensively for studies of insulin binding and insulin action in several pathophysiologic states, including obesity (8, 20, 21) , impaired glucose tolerance (10) , and diabetes mellitus (10, 22, 23) , the biochemical characteristics as well as the cellular fate of insulin receptors in this major human insulin target cell system remain to be determined. The main reason for this is the fact that the small amounts of adipose tissue that can be obtairred from patients for experimental studies are usually insufficient for detailed experimental characterizations using routine biochemical procedures. The technique of photoaffinity labeling of insulin receptors (16, 18, (24) (25) (26) Photoreactive insulin derivative. The preparation and characterization of the photosensitive insulin analogue used in this study, B2(2-nitro-4-azidophenylacetyl)des-PheB-insulin (NAPA-DP-insulin), have been described previously (27, 28) . This derivative is biologically active and is a full insulin agonist at saturating concentrations (18, 29) .
Iodination of NAPA-DP-insulin. NAPA-DP-insulin was iodinated in a dark room to a specific activity of 100-200 cpm/pg by using the water-insoluble oxidizing agent, 1,3,4,6-tetrachloro-3,6-diphenylglycoluril (IODO-GEN; Pierce Chemical Co., Rockford, IL) essentially as we have described previously (16) . The IODO-GEN was coated as a thin film (40 1Ag in 20 ,l of chloroform) to the bottom of 12 X 75-mm glass tubes. 10 Ag of NAPA-DP-insulin in 0.01 M HCl was reacted for 3 min with 3 mCi of Na'251 in 200 At of 0.1 M phosphate buffer (pH 7.5) in the IODO-GEN tube. The reaction mixture was then transferred to a clean test tube, and 50 4l of 10% BSA was added. This mixture was dialyzed against 0.1 M phosphate buffer (pH 7.5) containing 0.2% BSA to remove free 1251, and the iodinated product was stored in the dark at 4°C and used within 1 to 2 wk.
Preparation of isolated human adipocytes and measurement of binding to intact cells. Adipose tissue specimens were obtained from 13 normal subjects (7 males, 6 females) by open biopsy from the lower abdominal wall as described previously (8, 21) . The study subjects all had normal oral glucose tolerance and ranged in age from 23 to 73 yr (mean age, 37.9 yr). All biopsy procedures were performed in the Abbreviations used in this paper: CQ, chloroquine; IODO-GEN, 1,3,4,6-tetrachloro-3,6-diphenylglycoluril;
NAPA-DP-insulin, B2(2-nitro-4-azidophenylacetyl)desPheBl-insulin; NEM, N-ethylmaleimide; PMSF, phenylmethylsulfonylfluoride.
Clinical Research Center at the University of Colorado Health Sciences Center and informed consent was obtained in all instances.
Isolated adipocytes were prepared from the adipose tissue biopsy specimen by the collagenase digestion method of Rodbell (30) as described previously (15) . Cell counts were performed according to a modification of method III of Hirsch and Gallian (31) , in which the cells were fixed in 2% osmium tetroxide in 0.05 M collidine buffer (made isotonic with saline) for 24 h at 370C and then taken up in a known volume of isotonic saline for counting. Counting was performed with a model ZB Coulter Counter with a 400-,um aperture (Coulter Electronics Inc., Hialeah, FL). Measurement of 125I-labeled NAPA-DP-insulin ('251-NAPA-DP-insulin) binding to intact cells was carried out as previously described (15) .
Binding and photolysis of '251-NAPA-DP-insulin. Suspensions of isolated human adipocytes (-2.5 x 105 cells/ ml) were incubated with various concentrations of '25I-NAPA-DP-insulin in minimal essential medium containing 10 mM Hepes (pH 7.5) and 1% BSA. The incubations were carried out at 160C in the presence or absence of 0.2 mM CQ in aluminum foil-covered plastic scintillation vials. Native porcine insulin, 20 ug/ml, was included where appropriate to determine nonspecific binding. After the desired incubation periods, the cells were transferred to 60 X 15-mm plastic petri dishes and photolysis was carried out for 3 min by exposure to a long-wave (366 nm) ultraviolet (UV) lamp (BlakRay; Ultra-Violet Products, Inc., San Gabriel, CA) placed 10 cm from the cell samples. The cells were then transferred to polypropylene tubes, washed three times, and solubilized with 1% sodium dodecyl sulfate (SDS) containing 1 mM NEM and 2 mM PMSF. The protocols for the experiments designed to study internalization and cellular processing of the labeled insulin-receptor complexes are described in the appropriate figure legends. Polyacrylamide gel electrophoresis and autoradiography. The solubilized proteins from the photoaffinity labeled cells were analyzed by SDS-polyacrylamide gel electrophoresis according to the method of Laemmli (32) labeled nonreduced form of the insulin receptor, while the Mr-295,000 and -260,000 species were labeled less intensely ( Fig. 2 A) . The Mr values of the unreduced forms of the insulin receptor reported in this study should be considered only as estimates, since they were obtained by extrapolation of the standard molecular weight calibration curve above Mr 200,000 and also because of the known anomalous mobility of glycoproteins in SDS-polyacrylamide gels.
When the solubilized proteins from the photolabeled adipocytes were treated with dithiothreitol and then electrophoresed, all of the nonreduced forms of the insulin receptor were converted into only two specifically labeled bands of Mr 125,000 and 90,000 (Fig. 2  B) . In the reduced form of the receptor, almost all of the radioactive label is in the Mr-125,000 band, indicating that this subunit contains essentially all of the insulin binding sites of the receptor. The specific labeling of this binding subunit could be observed at 12511 NAPA-DP-insulin concentrations as low as 5 ng/ml (8.3 X 10-`M) and was saturable, reaching a maximum at 50-60 ng/ml of '251-NAPA-DP-insulin. In contrast, consistent photolabeling of the Mr 90,000 subunit was observed only at higher (.30 ng/ml) NAPA-DP-insulin concentrations (data not shown). At '25I-NAPA-DP-insulin concentrations as high as 90 ng/ml (15 nM) , only the M,-125,000 and -90,000 subunits of the insulin receptor were specifically labeled and no additional nonspecific bands were observed besides the single Mr, 84 ,000 protein (indicated by arrows in Fig. 2 and in the other autoradiograms in this paper), thus demonstrating the high degree of specificity of the photoreactive insulin analogue for the insulin receptor. When equal amounts of solubilized samples from the photolabeled cells were electrophoresed under both reducing and nonreducing conditions, the results from the multiple experiments showed that the total amount of radioactivity in the reduced forms of the receptor was approximately half of that in the nonreduced forms (data not shown). This indicates that during disulfide reduction with dithiothreitol, the interchain disulfide bonds of 1mI-NAPA-DP-insulin are also reduced and the A-chain is then lost together with approximately half of the total '25I-label in the iodinated insulin derivative; the B-chain remains covalently linked to the receptor. Fig. 3 shows the competition by native porcine insulin for the labeling of insulin receptors by '25I-NAPA-DPinsulin. Half-maximal inhibition of the labeling of the M,-125,000 subunit occurred at native insulin concentrations of 12 ng/ml (2 nM). This finding, together with the results shown in Fig. 2 , demonstrates that the NAPA-DP-insulin derivative specifically labels insulin receptors on isolated human adipocytes and that this labeling occurs at concentrations of the photoreactive insulin derivative that are well within the physiologic range of insulin concentrations.
Internalization and cellular processing of the labeled insulin-receptor complexes. The general experimental scheme that we have used to study the cellular fate of the photolabeled insulin receptors in human adipocytes is summarized in Fig. 4 . Since endocytotic internalization is inhibited at 16'C (33), and since the insulin receptor is highly sensitive to tryptic degradation (34, 35) , we used these facts to distinguish cell surface receptors from those that become translocated to the cell interior. Thus, at 16°C, essentially all of the labeled receptors should be on the cell surface and accessible to tryptic degradation. In contrast, further incubation of the photolabeled cells at 37°C would allow endocytosis and internalization to occur. Therefore, if insulin-receptor complexes are internalized in human adipocytes, then trypsinization of the photolabeled adipocytes at the end of the 37°C incubation should degrade only the receptors that remain on the cell surface while the internalized pool of receptors should be inaccessible to trypsin in the incubation medium. When the photolabeled adipocytes were trypsinized at various time points during their incubation at 370C, and then solubilized and electrophoresed under disulfide reducing conditions, the time course of the generation of trypsin-insensitive (intracellular) labeled Mr-125,000 insulin receptor subunits (Fig. 8) was essentially the same as that of the unreduced Mr-330,000 receptor species (Fig. 6) . Trypsin-insensitive Mr-125,000 subunits could be observed by 2 min and appeared to reach maximal amounts by 30-60 min of incubation at 370C. During this same period, a time-dependent increase in the amount of the M,-90,000 band can also be seen with a fall off occurring by 60 min. Since there was only minimal initial labeling of the Mr-90,000 (,) receptor subunit in this experiment (data not shown), the time-dependent increase in the M,-90,000 band seen in Fig. 8 indicates an increase in the generation by trypsin of the Mr-90,000 proteolytic peptide (shown in Fig. 7 , lane 4) with increasing time of incubation of the adipocytes at 37°C before trypsin exposure. The M,-115,000 peptide is not well visualized in Fig. 8 because of the smaller amount of cells used per lane in this experiment as compared with those in Fig. 7 . Fig. 8 also shows that after incubation of the labeled cells at 16°C for 30 (Fig. 9 A, lanes 1 and 3) . Furthermore, at 16°C, all of the labeled receptors remained on the cell surface in both the CQ-treated and untreated cells, since in each instance trypsin exposure degraded all of the labeled receptors ( Fig. 9 A, lanes 2 and 4) . In contrast, after 1-h incubation at 370C, a proportion of the M,-330,000 insulin receptor species became internalized in both the CQ-treated and untreated cells. However, in the presence of CQ, the intracellular pool of this receptor species was increased, as shown by the increased intensity of the Mr,330,000 band in the CQ-treated cells (compare lanes 6 and 8 in Fig. 9 A) .
Internalization and Processing of Insulin Receptors in Human Adipocytes
When the solubilized samples from the experiment described in Fig. 9 A were electrophoresed under disulfide reducing conditions, it was noted that after 1 h incubation at 37°C, the intracellular Mr-125,000 receptor pool was increased in the CQ-treated cells and furthermore, CQ also appeared to block the generation of the Mr-115,000 peptide (data not shown).
To assess the dynamics of insulin-receptor complexes in another human cell type, experiments identical to those described in Fig. 9 A were performed with cul- The experiment was performed exactly as described in A, except that cultured IM-9 lymphocytes were used.
tured human lymphocytes (IM-9), a widely studied cell line with high cell-surface insulin receptor concentrations, but in which there are no known glucoregulatory effects of insulin. Fig. 9 B shows that, unlike the finding in the adipocytes (Fig. 9 A) , no trypsin-insensitive or intracellular insulin-receptor complexes are seen in the IM-9 lymphocytes when the photolabeled cells were incubated for 1 h at 370C either in the absence (lane 6) or presence (lane 8) of 0.2 mM CQ. Fig. 10 shows the time course of the effect of CQ on the intracellular accumulation of labeled receptors in the human adipocytes at 370C. During the first 30 min of incubation, the effect of CQ to increase intracellular receptor accumulation was small. With a longer incubation period, however, the CQ effect became more pronounced and increasingly more labeled receptors were accumulated intracellularly between 60 and 120 min of incubation in the CQ-treated cells. By 120 min of incubation CQ caused an average of -50% increase in the amount of labeled intracellular receptors.
DISCUSSION
Although it has recently been shown that insulin receptors are internalized in rat adipocytes (16, 17) and hepatocytes (18, 19) , information regarding the metabolic fate of insulin receptors in human adipocytes has been lacking. The information derived from the animal cells, although very useful, cannot be directly extrapolated to human cell systems, since it is known that receptor regulation can occur by different mechanisms in different cell types and differences can also occur in the same cell types from different species. For example, whereas insulin receptors are internalized in rat adipocytes (16, 17) and hepatocytes (18, 19) , they are shed into the incubation media by IM-9 lymphocytes (26). Lack of cellular insulin receptor processing has also been reported in H4 hepatoma cells, although biologic effects of insulin can be demonstrated in these cells (42) . Furthermore, in the f3-adrenergic receptor system, it has been shown that hormone-induced desensitization of adenylate cyclase is associated with decreased receptor number in the frog erythrocyte, whereas in the turkey erythrocyte desensitization occurs without change in receptor number (43, 44) . Such findings indicate that differences in the mechanism of regulation of receptor number and hormone sensitivity can occur among different cell types (16-19, 26, 42) , and between the same cell types from different species (43, 44) .
In the present study, we used a photoaffinity labeling technique to characterize insulin receptors in isolated human adipocytes and to follow the cellular fate of the labeled receptors at physiologic temperatures. The results show that (a) the subunit structure of insulin receptors in human adipocytes is the same as that previously reported for several other cell types; (b) insulinreceptor complexes remain on the cell surface at 16'C, but at 370C these complexes are rapidly (within 2 min) internalized and their intracellular accumulation reaches a steady state within 30 min; and (c) the internalized insulin-receptor complexes are partially processed at CQ-sensitive intracellular sites, although the magnitude of the CQ effect appears to be less than that observed in rat adipocytes (16, 17) .
The NAPA-DP-insulin derivative used in our studies has been well characterized and retains almost all of the biological activity and receptor binding affinity of native porcine insulin (18, (27) (28) (29) 45) . At saturating concentrations, the binding of this derivative to isolated human adipocytes at 16'C was very rapid. Upon photolysis with a long-wave (366 nm) UV light source, ' 25% of the specifically bound ligand could be covalently linked to the cells (Fig. 1) and this process did not affect cell viability, as assessed by trypan blue exclusion. Analysis of the covalently bound radioactivity by gel electrophoresis and autoradiography revealed the specific labeling of insulin receptor proteins (Fig.  2) and only a single cell surface protein of Mr-84,000 was nonspecifically labeled in most of the experiments, thus indicating the high degree of specificity of NAPA-DP-insulin for the insulin receptor. Furthermore, physiologic concentration of native porcine insulin effectively inhibited the photolabeling of the receptors (Fig. 3) , indicating that both native insulin and NAPA-DP-insulin bind to the same ligand recognition sites of the receptor.
In the nonreduced state, the labeled insulin receptor species appeared primarily in the Mr-330,000 form, and to a lesser extent in the Mr-295,000 and -260,000 forms (Figs. 2, 5, and 9 A). The appearance of similar heterogeneous forms of unreduced insulin receptors has also been reported previously (46) . We have also shown (16) that when the nondenaturing detergent Triton X-100 was used for solubilization of photolabeled rat adipocytes, the nonreduced forms of the insulin receptor appeared primarily in the Mr-260,000 and, to a lesser extent, in the Mr,330,000 and -295,000 forms, thus indicating that conversion of the Mr,330,000 and -295,000 species into the Mr-260,000 form was occurring in vitro, possibly owing to the action of proteases co-solubilized with the labeled receptors. In the present study, although the use of 1% SDS (which, unlike Triton X-100, should denature proteases) partially reverses this conversion and yields the Mr,330,000 species as the major labeled form of the unreduced receptor, complete inhibition of the generation of the Mr-295,000 and -260,000 species was not achieved, despite inclusion of PMSF and NEM in the solubilizing solution (Figs. 2, 5, and 9 A). Thus, despite the likelihood that at least a portion of the heterogeneous forms of the unreduced insulin receptors are generated in vitro because of proteolysis during sample preparation (16, 46) , it is also possible that some of these heterogeneous receptor species are generated on the cell surface, possibly as a result of the initial binding of insulin to the receptor.
In this regard, it should be noted that a recent report has apppeared indicating that insulin affects the structural organization and binding characteristics of its own receptor in H35 rat hepatoma cells (47) . Thus, in future studies it will be important to determine the precise proportions of the oligomeric unreduced insulin receptor forms that may be generated in other insulin target cells under different physiologic conditions. Upon complete reduction of disulfide bonds, all of the three unreduced forms of the insulin receptor were converted into only two subunits of Mr-125,000 and -90,000 (Fig.   2 ). Essentially all of the radioactivity was contained in the Mr-125,000 band, indicating that this subunit represents the major insulin binding component of the receptor (24) (25) (26) 46) . Although the Mr-90,000 subunit does not participate in insulin binding to a major extent (Fig. 2) , it is an integral component of the insulin receptor macromolecule, as shown by biosynthetic labeling (48) and receptor purification (49) studies. Furthermore, based on the results of a series of recent important studies (50) (51) (52) (53) , it is becoming clear that the phosphorylation of this (,B) subunit is selectively stimulated by insulin and that this subunit itself has kinase activity (54) . Thus, the emerging picture is that the Mr-125,000-135,000 (a) subunit serves as a ligand recognition component of the receptor, while the Mr-90,000-95,000 (f,) subunit may be involved in the transduction or regulation of insulin action through specific insulin-induced phosphorylation of this subunit and other effector proteins.
In studying the cellular processing of the labeled insulin receptors, we interpreted the data to signify that the trypsin-sensitive receptors represent those still on the cell surface, while the trypsin-insensitive fraction represents the internalized pool of receptors and their intracellular degradation products (Fig. 4) . Differential sensitivity to trypsin has similarly been used previously to distinguish between cell surface and intracellular receptors for insulin (16) (17) (18) and epidermal growth factor (41 6 and 8 show that at 370C insulinreceptor complexes are translocated to the cell interior very rapidly (within 2 min) and that the intracellular accumulation of these complexes proceeds rapidly during the initial 30 min of incubation. Between 30 and 60 min of incubation, a steady state was reached and the intracellular pool of the insulin-receptor complexes remained constant. This suggests that after 30 min at 370C either further receptor internalization becomes slowed or the rate of degradation of the internalized receptors comes into balance with the rate of internalization of receptors.
The parallel time-dependent increase in the amount of the tryptic Mr-90,000 peptide and the internalized pool of Mr-125,000 receptor species at 370C (Fig. 8) suggest that the generation of the tryptic M,-90,000 peptide may be related to the internalization of insulinreceptor complexes. This notion is further supported by the finding that at 16'C neither internalized receptors nor tryptic Mr-90,000 peptide are seen (Fig.  8) . Furthermore, we have also recently found that in isolated rat adipocytes tryptic generation of the M, 90,000 proteolytic peptide is observed at 37°C and that the time-dependent formation of this peptide is directly correlated with the internalization of insulin-receptor complexes (55) . Thus, taken together, these results indicate that the internalization of insulin-receptor complexes occurs by similar mechanisms in both human and rat adipocytes.
Since CQ is known to have lysosomotropic effects (36, 37) and has also been shown to inhibit the intracellular degradation of internalized hormones and receptors (16, 17, 39- Fig. 9 B, the absence of any demonstrable receptor internalization and the lack of CQ effect in the IM-9 lymphocytes, a human cell line in which the fate of insulin receptors has been shown to be different from that in insulin target cells (26) , demonstrate the usefulness of the photoaffinity labeling approach in revealing differences in insulin receptor dynamics in insulin target and nontarget cells.
The observed minimal effect of CQ in increasing the intracellular accumulation of insulin-receptor complexes during the initial 30-min incubation at 37°C (Fig. 10) suggests that degradation of the internalized complexes, at least by CQ-sensitive mechanisms, is minimal during this period. The finding that a rapid increase in the intracellular accumulation of insulinreceptor complexes occurs during this same period (Fig.  6 ) is also consistent with this possibility, since a rapid increase in the internalized pool can occur only if there is a minimal degradation of this pool of receptors. The observation that the amount of intracellular insulinreceptor complexes reaches a plateau after 30 min at 370C (Fig. 6 ) and the finding that CQ causes a more pronounced increase in the intracellular pool of these complexes during this same period (Fig. 10) indicate that significant degradation of the internalized insulinreceptor complexes begins after 30 min incubation at 37°C. This raises the possibility that insulin receptors are initially internalized into a subeellular compartment in which degradation of the receptors does not occur, and that after some time the internalized receptors are transported to a compartment in which degradation readily occurs.
The overall effect of CQ to inhibit the degradation of internalized insulin-receptor complexes in the human adipocytes is quantitatively less than its effects in rat adipocytes (16, -17) . This difference in the magnitude of the CQ effect is unlikely to be due to the possibility that internalization of insulin-receptor complexes occurs more slowly in human compared with rat adipocytes, since similar rapid rates of internalization are observed in both cell types (Figs. 6 and 8, and reference 55). Thus, it seems possible that the smaller CQ effect in human adipocytes may be due to a smaller proportion of overall receptor degradation via a CQ-sensitive pathway in these cells as compared with rat adipocytes. Furthermore, since the human adipocytes were obtained from subcutaneous adipose tissue, and the rat adipocytes from epididymal fat pads, differences in insulin-receptor metabolism may exist in the same cell types obtained from different regions of the body. In this regard, it is of interest to note that a recent report by Bolinder et al. (57) indicates that despite similar receptor numbers per cell, human subcutaneous and omental fat cells show marked differences in insulin receptor affinity, and in their sensitivity to the antilipolytic effects of insulin. Additionally, variations in glucose metabolism and insulin response by fat cells isolated from three different adipose tissue depots of the rat have also been described (58) .
It should be noted that in the present study we followed the fate of covalently linked insulin-receptor complexes. Since under normal physiologic conditions the interaction of insulin with its receptors is noncovalent, it can be doubted whether internalization and processing of covalently linked insulin-receptor complexes is different from that which occurs normally under physiologic conditions. In a previous study with rat adipocytes, however, we have demonstrated that intracellular insulin receptor can be identified by photoaffinity labeling after allowing insulin-induced receptor internalization to occur, and that CQ inhibited degradation of the internalized pool of receptors (59) . Thus, the internalization of insulin receptors appears to occur by the same process, whether the fate of the receptor is followed without covalent modification (17, 59) or after covalent linking of insulin to the receptor (16) on the cell surface.
In summary, we used photoaffinity labeling techniques to characterize insulin-receptor complexes in isolated human adipocytes and demonstrated that at physiologic temperatures these complexes are rapidly internalized and subsequently processed at one or more CQ-sensitive intracellular sites. In future studies, it will be of interest to investigate the detailed pathways and subcellular locations of insulin receptor processing in human adipocytes and to determine whether abnormalities in these pathways exist in pathophysiologic states.
